Healthleap raises $38m in seed and Series A for hospital AI

Healthleap raises $38m in seed and Series A for hospital AI

7 October 2026: Healthleap, a San Francisco company whose software scans hospital patient records for conditions that go undiagnosed, has raised $38 million in combined seed and Series A funding from Sequoia Capital, First Round Capital and Hummingbird Ventures. The release does not say how the sum divides between the two rounds and names no earlier funding.

Not yet independently verified. Single source: the company's wire release. It does not split the $38m between the seed and Series A rounds, and the customer and revenue figures are the company's own. We will update this when it can be confirmed, and remove this note.

The product reads each adult inpatient's full record every morning, ranks which patients need attention first, and sends risk scores into clinical workflows through the hospital's electronic health record system. Healthleap says it screens every adult inpatient daily at more than 50 hospitals and holds HIPAA compliance and SOC 2 certification. It names Penn Medicine, Houston Methodist, Cedars-Sinai and Emory Healthcare as customers.

It begins with malnutrition. The company says up to half of hospitalised patients are at risk but fewer than 9% are formally diagnosed, that the condition costs the US health system up to $58 billion a year, and that a hospital can claim about $11,000 in reimbursement for each severe malnutrition diagnosis. It calls its product the first and only validated AI malnutrition screening tool with a screening layer built into the health record.

The release also carries results it attributes to customers. One Penn Medicine hospital is said to credit Healthleap with $23.8 million a year, counting extra reimbursement and shorter stays. Alfred Lin of Sequoia cites a health system that found and treated 39% more malnutrition cases and booked $11 million in incremental revenue.

The new money will widen the product to more conditions, namely congestive heart failure, pressure ulcers and several hospital-acquired infections, and pay for hires in engineering, sales, customer success and product.

Josiah Meyer is chief executive and co-founder; his sister Jemima Meyer, a clinician, co-founded the company in 2022. The announcement was made in San Francisco on 7 October 2026.

Sources

• Healthleap (via WebWire press release), 7 October 2026